Susquehanna International Group’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $197K | Buy |
169,986
+73,519
| +76% | +$85.3K | ﹤0.01% | 5560 |
|
|
2025
Q1 | $130K | Buy |
96,467
+27,893
| +41% | +$37.7K | ﹤0.01% | 5745 |
|
|
2024
Q4 | $903K | Buy |
68,574
+21,936
| +47% | +$289K | ﹤0.01% | 3150 |
|
|
2024
Q3 | $523K | Buy |
46,638
+17,202
| +58% | +$193K | ﹤0.01% | 3594 |
|
|
2024
Q2 | $316K | Buy |
29,436
+6,691
| +29% | +$71.9K | ﹤0.01% | 4143 |
|
|
2024
Q1 | $339K | Sell |
22,745
-54,862
| -71% | -$817K | ﹤0.01% | 4026 |
|
|
2023
Q4 | $1.41M | Sell |
77,607
-66,901
| -46% | -$1.21M | ﹤0.01% | 2388 |
|
|
2023
Q3 | $2.51M | Buy |
144,508
+85,624
| +145% | +$1.48M | ﹤0.01% | 1630 |
|
|
2023
Q2 | $1.07M | Sell |
58,884
-538,987
| -90% | -$9.77M | ﹤0.01% | 2632 |
|
|
2023
Q1 | $15.9M | Buy |
597,871
+172,975
| +41% | +$4.6M | ﹤0.01% | 528 |
|
|
2022
Q4 | $8.21M | Buy |
424,896
+362,799
| +584% | +$7.01M | ﹤0.01% | 692 |
|
|
2022
Q3 | $1.3M | Buy |
62,097
+12,305
| +25% | +$257K | ﹤0.01% | 2192 |
|
|
2022
Q2 | $399K | Buy |
+49,792
| New | +$399K | ﹤0.01% | 3628 |
|
|
2022
Q1 | – | Sell |
-29,103
| Closed | -$393K | – | 6340 |
|
|
2021
Q4 | $393K | Buy |
29,103
+11,955
| +70% | +$161K | ﹤0.01% | 4135 |
|
|
2021
Q3 | $289K | Buy |
17,148
+10,189
| +146% | +$172K | ﹤0.01% | 4332 |
|
|
2021
Q2 | $203K | Sell |
6,959
-18,639
| -73% | -$544K | ﹤0.01% | 4826 |
|
|
2021
Q1 | $1.01M | Buy |
25,598
+11,044
| +76% | +$434K | ﹤0.01% | 2994 |
|
|
2020
Q4 | $331K | Sell |
14,554
-23,113
| -61% | -$526K | ﹤0.01% | 3809 |
|
|
2020
Q3 | $853K | Buy |
+37,667
| New | +$853K | ﹤0.01% | 2418 |
|